Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Website: jnj.com


  • Good financial results growth rate 248.9% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (8.1%)
  • Dividend yield for the last twelve months 3.3%
  • Free cash flow yield 0.0% (LTM)
  • Share price is 1.7% higher than minimum and 21.0% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (14.4x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: JNJ
Share price, USD:  (0.0%)146.97
year average price 157.96  


year start price 154.35 2023-05-29

max close price 174.48 2023-07-28

min close price 144.45 2024-04-16

current price 146.97 2024-05-27
Common stocks: 2 631 399 832

Dividend Yield:  3.3%
EV / LTM EBITDA: 14.4x
EV / EBITDA annualized: 13.8x
Last revenue growth (y/y):  -13.6%
Last growth of EBITDA (y/y):  200.0%
Historical revenue growth:  2.9%
Historical growth of EBITDA:  13.2%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 386 737
Net Debt ($m): 32 590
EV (Enterprise Value): 419 327
EBITDA LTM ($m): 29 048
EV / LTM EBITDA: 14.4x
Price to Book: 5.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-05-24zacks.com

Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know

2024-05-24nypost.com

Cancer victims file class action against Johnson & Johnson over ‘fraudulent' bankruptcies

2024-05-22reuters.com

Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies

2024-05-22businesswire.com

Proposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc Litigation

2024-05-22investorplace.com

7 Safe-Haven Stocks to Weather Any Storm

2024-05-16zacks.com

Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?

2024-05-16reuters.com

Johnson & Johnson to acquire Proteologix for $850 million

2024-05-14Seeking Alpha

Johnson & Johnson (JNJ) Management Presents at BofA Securities Health Care Conference (Transcript)

2024-05-14Zacks Investment Research

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

2024-05-13Market Watch

J&J's $13 billion bid for Shockwave turns to Wall Street for funding
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data